Do You Know Your NOACs? Let’s Review the Novel Oral Anticoagulants

Do You Know Your NOACs? Let’s Review the Novel Oral Anticoagulants is organized by AchieveCE.

Activity Release Date: May 2, 2021
Activity Expiration Date: Jul 31, 2027

Activity Overview:
When it comes to oral anticoagulants, warfarin is no longer the only game in town. The past decade has brought new oral anticoagulant therapy with novel mechanisms of action. Whether practising in a health system or community setting, understanding the uses, new mechanisms of action and differences between these new agents is crucial to exceptional patient care.

This activity will review the four novel oral anticoagulants (NOACs): apixaban, dabigatran, edoxaban, and rivaroxaban, and will discuss their mechanism of action, indications, dosing, adverse effects and drug interactions. The activity will include a review of the anticoagulation cascade with a focus on the place of each drug in the cascade and how they differ from

warfarin. Other discussions will include the role of NOACs in the treatment of atrial fibrillation and prevention of deep vein thrombosis and pulmonary embolism based on current CHEST guidelines as well as those developed by the American College of Cardiology, American Heart Association, and European Society of Cardiology. Lastly, the activity will present various counselling points, precautions, and boxed warnings pertinent to patient care.

Pharmacist Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Review the mechanisms of action, indications, adverse effects, drug interactions, and counselling points for the four novel oral anticoagulants (NOAC)
• Review the anticoagulation cascade and where each NOAC fits based on the mechanism of action
• Discuss the role of NOACs in the treatment of atrial fibrillation and prevention of venous thromboembolisms based on current treatment guidelines

Pharmacy Technician Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Recognize four novel oral anticoagulants (NOAC)
• Discuss indications, dosing, side effects, and drug interactions for each NOAC
• Identify precautions and warnings for each NOAC

Nurse Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Recognize four novel oral anticoagulants (NOAC)
• Discuss indications, dosing, side effects, and drug interactions for each NOAC
• Identify precautions and warnings for each NOAC